A director at Pulse Biosciences Inc sold 50,000 shares at 17.420USD and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Lockout Rally Continues; Breakouts Piling Up Since our 11/21/23 Compass we have discussed on a weekly basis that even a minor 2-5% pullback is far from a guarantee, considering "breakaway gaps" and what appeared to be an ongoing "lockout rally," while also discussing that we would be buyers if a pullback did happen. All we got was a 1% peak to trough decline in the S&P 500, while the Nasdaq 100 (QQQ) pulled back 2.9% (though left the 11/14/23 gap unfilled). Now, the SPX and QQQ are breaking out...
BAH, HURN, NOTV, PAGS, SPOK, ROKU, BZH, HOV, MTH, SKX, SAM, DESP, BJRI, RKLB, IONQ, KLAC, INTC, CNX, CLB, CRK, OVV, SOFI, TROW, AX, CINF, DLR, ABR, RWT, BFST, INBK, AUPH, BBIO, DSGN, RPHM, URGN, RCEL, AXNX, CUTR, PLSE, In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patte...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.